Novartis
Business Profile
Core Value Proposition
Novartis provides innovative medicines to improve and extend people’s lives.
Target Customer
{"Patients and caregivers","Healthcare professionals","Researchers","Healthcare organizations (e.g., hospitals and clinics)"}
Key Differentiator
{"Global reach of innovative medicines (patients reached worldwide)","Broad therapeutic areas and pipeline across cardiovascular, immunology, neuroscience, oncology","Global Managed Access Programs (gMAP) and dedicated access principles","Novartis Gene Therapies capability"}
Implementation Timeline
Not specified in the provided content
Pain Points
- 1Access to innovative medicines across diverse markets and patient populations
- 2Need for reliable information for patients and caregivers, including clinical trial recruitment and side effects reporting
- 3Complexity of obtaining medicines via managed access and country-specific programs
Key Features
- 1Extensive product pipeline across multiple therapeutic areas
- 2Novartis Foundation and ESG-driven initiatives
- 3Managed access programs (including Zolgensma Global Managed Access Program)
- 4Resources for patients and healthcare professionals by country
- 5Global manufacturing and R&D expansion (and a focus on scaling innovation)
Target Customer Industries
Decision Makers
- 1Board of Directors
- 2Executive Committee
Client Results
- 1Medicines reaching 296 million people worldwide
Competitive Advantages
- 1Global patient reach and scale
- 2Integrated access programs and commitment to patient care
- 3Strong focus on research & development and breakthrough science
- 4Gene therapy capabilities (Novartis Gene Therapies)
Key Benefits
Additional Product Information
Product Description
Novartis is an innovative medicines company focused on reimagining medicine to improve and extend lives, with a broad pipeline and global access programs.
Target Market
Global patients and healthcare systems, with resources for patients, caregivers, and healthcare professionals worldwide
Unique Value Proposition
Innovative medicines company combining breakthrough science with patient access programs and a broad, multi-therapeutic pipeline, including gene therapies
Technical Requirements
Not specified
Pricing Model
Not specified
Companies Solving Similar Problems
Based on matching: problems solved, target roles, key features, industries
Vodafone Business
Vodafone provides technology communications solutions to connect society and build a digital future in Europe and Africa.
OpenJS Foundation
OpenJS Foundation provides a neutral home and support for JavaScript and web technologies
Asthma and Allergy Foundation of America (AAFA)
Asthma and Allergy Foundation of America (AAFA) provides education, advocacy, and research resources for people with asthma and allergies.
Wi-Fi Alliance
Wi-Fi Alliance provides globally interoperable Wi-Fi solutions that connect everyone and everything, everywhere.
Infectious Diseases Society of America (IDSA)
Infectious Diseases Society of America (IDSA) provides a global community of infectious diseases clinicians, scientists and public health experts with access to research, education opportunities, news, and policy advocacy to advance the treatment and prevention of infectious diseases and health equity.
Total Quality Assurance (ATIC) Services
Intertek provides Total Quality Assurance (ATIC) services—Assurance, Testing, Inspection, and Certification—to identify and mitigate risks in operations, supply chains, and quality management systems, ensuring safety, sustainability, and performance of products and services.
Get More Profiles Like This
Join 2,000+ professionals getting weekly sales intelligence updates from GoAgentic
Ready to Transform Your Sales Pipeline?
Join 700+ sales professionals automating outreach with AI.
Start Free Trial
No credit card required